Every patient deserves to know if their breast cancer is hereditary, if their treatment could be more precise and if their ...
Pediatric low‑grade gliomas (pLGGs) have distinct biology and treatment strategies compared to adult gliomas. These Chinese consensus guidelines ...
A presentation at the 2026 ONA Summit described the role of oncology nurses in managing the care of patients with NF-1 and PN undergoing treatment with MEK inhibitors.
Rare Pediatric Disease Designation may render Pasithea eligible to receive a Priority Review Voucher (PRV)MIAMI, April 20, ...
Freudenberg Home and Cleaning Solutions (FHCS) has successfullycompleted its voluntary public takeover of Nilfisk and has becomemajority shareholder with more than 90 % of the share capital and theass ...
Alexion to deliver 20 presentations across gMG, NF1 plexiform neurofibromas and neuromyelitis optica spectrum disorder at AAN meeting: Cambridge, UK Saturday, April 11, 2026, 18:0 ...
Alexion, AstraZeneca Rare Disease, will deliver 20 presentations, including five oral presentations across generalised myasthenia gravis (gMG ...
Modeling Individual-Level Uncertainty From Missing Data in Multifactorial Breast Cancer Risk Prediction Neurofibromin 1 (NF1) mutations, the third most common driver mutation in melanoma, occur in ...
Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic ...
Lung cancer, glioma, melanoma, sarcoma, and gynecologic tumors showed the highest pathogenic NF1 variant frequencies. Their analysis demonstrated that only one-third of detected NF1 variants were ...
What Is Koselugo, and Why Does It Matter? Koselugo (selumetinib) is an oral medicine that helps slow the growth of certain tumors. The FDA has approved it for adults with neurofibromatosis type 1 (NF1 ...
Treatment for neurofibromatosis type 1 may involve surgery, radiation therapy, or medication. In some cases, treatment may not be necessary unless symptoms become bothersome. Neurofibromatosis type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results